Evaluation of the Relationship Between Electrical Activity of the Diaphragm and Respiratory Mechanics During Neurally Adjusted Ventilatory Assist in Lung Transplant Patients and in Patients Affected by Acute Respiratory Failure.

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Protective ventilatory strategy should be applied to reduce ventilator-induced lung injury (VILI) after Lung Transplantation (LTx) or in case of acute respiratory failure requiring invasive mechanical ventilation. Neurally Adjusted Ventilatory Assist (NAVA) is an assisted ventilation mode in which respiratory support is coordinated by the electrical activity of the diaphragm (EAdi). Aim of the study is to assess the physiological relationship between neural respiratory drive, as assessed by EAdi, and tidal volume, driving pressure, and mechanical power, at different levels of ventilatory assist, in the absence of pulmonary vagal afferent feedback or during acute respiratory failure. Additional parameters will be collected: Pmus, Pocc, transpulmonary pressure etc.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age \> 18 y.o.

• Admission to ICU for post-operative monitoring after LTx or acute respiratory failure needing invasive mechanical ventilation

• Presence of spontaneous breathing activity

• Sedation titrated to a target RASS between 0 and -2

• Written informed consent obtained

Locations
Other Locations
Italy
Institute of Anaesthesia and Intensive Care, Padua University hospital
RECRUITING
Padua
Contact Information
Primary
Annalisa Boscolo, MD
annalisa.boscolobozza@aopd.veneto.it
+390498213090
Backup
Nicolò Sella, MD
nico.sella@hotmail.it
+390498213090
Time Frame
Start Date: 2022-12-27
Estimated Completion Date: 2025-12-27
Participants
Target number of participants: 40
Treatments
Experimental: NAVA group
Nava ventilation
Related Therapeutic Areas
Sponsors
Leads: University of Padova

This content was sourced from clinicaltrials.gov